Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Ketamine as a Rapid Sequence Induction Agent in the Trauma Population: A Systematic Review

Research output: Contribution to journalReviewResearchpeer-review

  1. Inhaled Sedation in the Intensive Care Unit: A New Option and Its Technical Prerequisites

    Research output: Contribution to journalJournal articleCommunication

  2. Acute Kidney Injury and Risk of Death After Elective Surgery: Prospective Analysis of Data From an International Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Anesthesia in Enhanced Recovery Pathways for Hip and Knee Arthroplasty: Where Is the Evidence?

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. A high fraction of inspired oxygen may increase mortality in intubated trauma patients - A retrospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Nationwide study found higher paediatric readiness in emergency departments and trauma centres with a paediatrician on-site

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Postoperative complications: an observational study of trends in the United States from 2012 to 2018

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The choice of drug used to facilitate endotracheal intubation in trauma patients during rapid sequence induction (RSI) may have an impact on survival. Ketamine is commonly used in the hemodynamically unstable trauma patient although it has been associated with side effects. This review sought to investigate whether ketamine should be preferred over other induction agents for RSI in trauma patients. PubMed, Embase, and the Cochrane Library were systematically searched on September 19, 2016 for studies reporting RSI of adult trauma patients with ketamine compared with another induction agent (etomidate, propofol, thiopental, or midazolam). No language restrictions were applied. The primary outcome was 30-day mortality, and secondary outcomes included information on blood transfusions, length of hospital stay, and hospital mortality. Risk of bias was assessed using the Cochrane Risk of Bias assessment tool for randomized trials and the Risk of Bias in Non-Randomized Studies of Interventions for nonrandomized studies of intervention. A total of 4 studies were included. A cohort study from 1976 compared thiopental (n = 26) with ketamine (n = 14) for RSI in trauma patients. The primary outcome was number of blood transfusions, and no significant difference was found. Risk of bias was judged to be serious. A randomized controlled trial from 2009 compared etomidate (n = 57) with ketamine (n = 47) and found no significant difference in 28-day mortality (odds ratio [OR], 0.8 [0.4-2.0]). The trial was judged to have a low risk of bias. Two cohort studies from 2015 and 2017 also compared etomidate (n = 116 and n = 526) with ketamine (n = 145 and n = 442). No significant difference in hospital mortality between the groups was observed (OR, 1.11 [0.38-3.27] and OR, 1.41 [0.91-2.16], respectively). Both studies were judged to have a moderate risk of bias, thus excluding the possibility of a meaningful meta-analysis. The study from 2017 also reported number of units of blood transfused during the first 48 hours after trauma and length of hospital stay. No significant differences were observed (OR, 1.14 [0.87-1.49] and OR, 1.1 [0.95-1.27], respectively). Extremely few studies have compared induction agents for RSI in trauma patients. No significant differences have been found in mortality, length of hospital stay, or number of blood transfusions after induction with ketamine compared to other induction agents, but a clinically relevant benefit or harm cannot be excluded.

Original languageEnglish
JournalAnesthesia and Analgesia
Issue number3
Pages (from-to)504-510
Number of pages7
Publication statusPublished - Mar 2019

    Research areas

  • Anesthetics, Dissociative/administration & dosage, Humans, Ketamine/administration & dosage, Length of Stay/trends, Mortality/trends, Multiple Trauma/diagnosis, Observational Studies as Topic/methods, Randomized Controlled Trials as Topic/methods, Rapid Sequence Induction and Intubation/methods

ID: 59437321